Scott Gottlieb confirmed as FDA commissioner
WASHINGTON — By a vote of 57 to 42 (with one Senator not voting), the Senate on Tuesday confirmed the nomination of Scott Gottlieb, of Connecticut, to be commissioner of the Food and Drug Administration, Department of Health and Human Services
“We are excited to partner with Dr. Gottlieb to protect and promote the health of the American people," stated Secretary Tom Price, HHS, following the news. "Dr. Gottlieb brings considerable experience to the FDA. His background will be crucial for keeping the FDA as the gold standard for safe treatments while advancing new, innovative solutions to the many public health challenges our nation faces," he said. "I am confident Dr. Gottlieb will make decisions that reduce regulatory burdens while protecting public health."
The appointment was welcomed by industry, as well.
In a congratulatory letter to Gottlieb, Scott Melville, president and CEO of the Consumer Healthcare Products Association, pledged the commitment of the his association to "empowering consumer self-care by preserving and expanding choice and availability of consumer healthcare products."
"You take this role at an exciting and challenging time," Melville wrote. "From our industry's perspective, now more than ever, Americans want to be empowered to make smart and effective healthcare choices," he added. Melville expressed optimism regarding Gottlieb's Sentate testimony in regards to OTC monograph reform. "We, too believe the time is now to ensure the OTC monograph system is as responsive and innovative for the American public as possible"
“CRN welcomes Dr. Scott Gottlieb’s confirmation," stated Steve Mister, president and CEO for the Council for Responsible Nutrition. "His prior experience at the Agency, combined with his medical background and his understanding of industry, all bolster our confidence that he is well-qualified to lead the FDA. Dr. Gottlieb will bring the right balance of concern for consumer safety, focus on product integrity and protection of consumer access to a wide array of dietary supplement products."
Gottlieb is among the 71% of Americans who take a dietary supplement, Mister added. "Further, we are encouraged by his statement during his confirmation that the Dietary Supplement Health and Education Act is the right framework for regulating our industry."
Gottlieb had served as a deputy FDA commissioner and a high-ranking official at the Centers for Medicare and Medicaid Services during the George W. Bush administration.
“We are excited to partner with Dr. Gottlieb to protect and promote the health of the American people," stated Secretary Tom Price, HHS, following the news. "Dr. Gottlieb brings considerable experience to the FDA. His background will be crucial for keeping the FDA as the gold standard for safe treatments while advancing new, innovative solutions to the many public health challenges our nation faces," he said. "I am confident Dr. Gottlieb will make decisions that reduce regulatory burdens while protecting public health."
The appointment was welcomed by industry, as well.
In a congratulatory letter to Gottlieb, Scott Melville, president and CEO of the Consumer Healthcare Products Association, pledged the commitment of the his association to "empowering consumer self-care by preserving and expanding choice and availability of consumer healthcare products.""You take this role at an exciting and challenging time," Melville wrote. "From our industry's perspective, now more than ever, Americans want to be empowered to make smart and effective healthcare choices," he added. Melville expressed optimism regarding Gottlieb's Sentate testimony in regards to OTC monograph reform. "We, too believe the time is now to ensure the OTC monograph system is as responsive and innovative for the American public as possible"
“CRN welcomes Dr. Scott Gottlieb’s confirmation," stated Steve Mister, president and CEO for the Council for Responsible Nutrition. "His prior experience at the Agency, combined with his medical background and his understanding of industry, all bolster our confidence that he is well-qualified to lead the FDA. Dr. Gottlieb will bring the right balance of concern for consumer safety, focus on product integrity and protection of consumer access to a wide array of dietary supplement products."
Gottlieb is among the 71% of Americans who take a dietary supplement, Mister added. "Further, we are encouraged by his statement during his confirmation that the Dietary Supplement Health and Education Act is the right framework for regulating our industry."
Gottlieb had served as a deputy FDA commissioner and a high-ranking official at the Centers for Medicare and Medicaid Services during the George W. Bush administration.